How long is the duration of treatment with mobosetinib?

Mobosetinib is an oral tyrosine kinase inhibitor. The median duration of treatment with mobosetinib (mDoT) was 5.6 months in responders and 8.6 months in responders. Mobosetinib is a kinase inhibitor. The chemical name of mobosetinib succinate is 2-[5-(Acrylamino)-4-{[2-(Dimethylamino span>)ethyl](methyl)amino}-2-methoxyanilinyl]-4-(1-methyl-1H-indole< /span>-3-base)pyrimidine-5-carboxylate succinate. The molecular formula is C32H39N7O4+ C4H6O4(succinate), which corresponds to a molecular weight of 703.8 grams/ moles. If you want to get more high-quality information, you can contact Yaode, and Yaode will do its best to help you learn more about high-quality overseas drugs.